Skip to main content

Table 3 Principal studies reporting GI cancers PDOs in co-culture with immune cells

From: Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool

Type of organoids

Immune cells

Aims Co-culture

Results

References

Colorectal tumor organoids

Lymphocyte from Peripheral blood

Analysis of specific-tumor T cells response against cancer cells in a personalized profile

Generation of co-culture between tumor cells and autologous PBMC. Generation of TCD8 reactive against tumor cells

[103]

Colorectal cancer organoids

Development new protocol to organoids from tissue airface that retain the components present into to the tumor for a day

Generation of organoids 2.0 which retain microenvironment of the tumor included T cells

Preservation of tumor microenvironment, but limited time for use

[105]

Mouse intestinal organoids

Intraepithelial Lymphocyte (IELs)

Evaluating the interaction between intestinal epithelial cells and intraepithelial lymphocyte

Generation of co-culture in presence of cytokines. Multi-directional movement to IELs along of surface present in organoids

[117]

Gastric organoids

Dendritic cells and T cells from peripheral blood

Evaluate the interaction between cancer cells infected with H. pylori and immune cells

Organoids infected with H. pylori expressed PD-L1 immune checkpoint and suppressed the T cells response

[56]

Mouse gastric organoids

Dendritic cells and T cells

Evaluate the role of Hh signaling in PD-L1 expression

Understand the feasibility such as a model to predicted immunotherapy response in gastric cancer

Treatment with anti-PD-1 induced apoptosis in tumor cells

Generation of murine models of co-culture organoids-immune cells

[118]

Pancreatic cancer organoids

Multy-cells type (fibroblast and T cells)

Generate and characterized the models of co-culture and demonstrated the applicability in pancreatic cancer

Demonstrated a tumor microenvironment generated by the co-culture of pancreatic organoids with stroma and immune cells

[119]

Cholangiocarcinoma cancer organoids

PBMC or T cells (Healthy control)

Establish and optimize a 3D co-culture model for study the growth, inhibition of organoid cell death by cytotoxic activity of T cells

The results demonstrated the different response between patients, and the capacity to the T-cells to generate cytotoxicity activity against the organoids

[57]

  1. PBMC peripheral blood mononuclear cells, TCD8 T cells type CD8, PD1 programmed cell death protein 1, PD-L1 programmed death-ligand 1